-- Favorable Safety Profile: PAS-004 has been well-tolerated with all treatment-related adverse events Grade 1 or 2, no ocular or cardio toxicity, and limited rash, nausea, diarrhea, and vomiting to ...

The Brisbane Cancer Conference is a premier oncology meeting that brings together leading international researchers, clinicians and industry experts working in the fields of translational oncology, ...

Guselkumab (Tremfya; Johnson & Johnson) continued to reduce signs and symptoms of active psoriatic arthritis (PsA) and ...

Ongoing research in renal cell carcinoma (RCC) suggests that hypoxia-inducible factor 2-α (HIF-2α) inhibitors are poised to ...

Company achieved FDA alignment on Phase 3 Oz-V trial for the treatment of 2L+ OPSCC, which will evaluate dual primary endpoints with potential of ...

New research from Spherix Global Insights finds that while Amgen's Tepezza (teprotumumab) continues to anchor the treatment landscape for thyroid eye disease (TED), physicians emphasize ongoing unmet ...

Last month, Karada welcomed Manila Standard Lifestyle for an experiential look at its Japanese body therapy approach, one that frames body care not as ...

Arrowhead Clinic Chiropractor Savannah is highlighting the urgent need for prompt medical evaluation and treatment of whiplash injuries following auto accidents, as delayed care can lead to chronic ...

Moment of Clarity has published a new educational resource titled “Transcranial Magnetic Stimulation (TMS) for PTSD“, which explores how noninvasive brain stimulation technology is transforming mental ...